Then we overexpressed or silenced SVIL‐AS1 in MCF‐10A AKT1E17K, IHH4 (papillary thyroid carcinoma cell), and KU‐19‐19 (bladder carcinoma cell), which all had the AKT1E17K mutation (Figure 2C,F). Here, SVIL is linked to differentiated thyroid carcinoma.